Star Imaging and Path Lab Ltd
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.[1]
- Market Cap ₹ 112 Cr.
- Current Price ₹ 64.2
- High / Low ₹ 152 / 59.0
- Stock P/E 5.66
- Book Value ₹ 61.4
- Dividend Yield 0.00 %
- ROCE 34.7 %
- ROE 40.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 1.05 times its book value
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.9%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 222 days.
- Working capital days have increased from 43.5 days to 121 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of BSE SME IPO
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 69 | 58 | 79 | 84 | 86 | |
| 54 | 52 | 55 | 54 | 52 | |
| Operating Profit | 15 | 6 | 23 | 29 | 34 |
| OPM % | 21% | 10% | 30% | 35% | 40% |
| 0 | 0 | 1 | 0 | 1 | |
| Interest | 2 | 2 | 3 | 3 | 3 |
| Depreciation | 4 | 3 | 5 | 5 | 5 |
| Profit before tax | 9 | 1 | 16 | 21 | 27 |
| Tax % | 33% | 35% | 23% | 26% | |
| 6 | 1 | 12 | 16 | 20 | |
| EPS in Rs | 41.93 | 3.87 | 82.80 | 11.80 | 12.96 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 7% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 36% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 34% |
| Last Year: | 41% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 14 | 17 |
| Reserves | 17 | 17 | 30 | 34 | 89 |
| 30 | 27 | 31 | 33 | 20 | |
| 10 | 16 | 20 | 18 | 23 | |
| Total Liabilities | 58 | 61 | 82 | 98 | 150 |
| 15 | 19 | 22 | 21 | 26 | |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 43 | 42 | 60 | 77 | 124 | |
| Total Assets | 58 | 61 | 82 | 98 | 150 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 14 | 5 | 18 | -6 | |
| -4 | -7 | -7 | -4 | |
| -7 | -5 | 2 | -0 | |
| Net Cash Flow | 3 | -7 | 13 | -10 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 85 | 110 | 152 | 222 |
| Inventory Days | ||||
| Days Payable | ||||
| Cash Conversion Cycle | 85 | 110 | 152 | 222 |
| Working Capital Days | 6 | -13 | 23 | 121 |
| ROCE % | 6% | 34% | 35% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| CT Scan Machines Infrastructure Number ・Standalone data |
|
||
| MRI Machines Infrastructure Number ・Standalone data |
|||
| Number of PPP Centers Number ・Standalone data |
|||
| Pathology Tests Number of Tests |
|||
| Radiology Tests - CT Scan Number of Tests |
|||
| Radiology Tests - MRI Number of Tests |
|||
| Radiology Tests - X-Ray Number of Tests |
|||
| Total Diagnostic Centers Number ・Standalone data |
|||
Documents
Announcements
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Empanelment With Bureau Of Indian Standards (BIS) And Indraprastha Power Generation Company Limited (IPGCL)
9 Feb - 09-Feb-2026: Empanelled with BIS and IPGCL to provide diagnostic and laboratory services at CGHS rates.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Empanelment With National Institute Of Educational Planning And Administration (NIEPA)
22 Jan - Empanelled by NIEPA to provide diagnostic and lab services to employees at CGHS-approved rates.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Empanelment With Indian National Science Academy (INSA)
21 Jan - INSA empanels Star Imaging for five-year CGHS-rate diagnostic and lab services for officers, employees, dependents.
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Acceptance Of Request For Providing Credit/Cashless Medical Services To All Serving Officer(S)/Official(S) Of The High Court Of Delhi
21 Jan - High Court of Delhi accepted Star Imaging's credit/cashless medical services for officers and dependents.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Central Electricity Regulatory Commission (CERC)
14 Jan - Star Imaging empanelled by CERC for medical diagnostic and lab services at CGHS rates, valid three years from letter.
Business Profile[1]
Star Imaging and Path Lab Limited (originally Janta X-Ray Clinic) is a Delhi-based diagnostic healthcare service provider offering pathology, radiology, cardiology, and neurology services. The company operates through B2C, B2B, and B2G models, with NABL-accredited facilities.